Recalls & Warnings April 01, 2017 Maker of Prelief, Urinozinc Prostate Health Formula Warned for Manufacturing Violations On March 16, 2017 the FDA issued a warning letter to DSE Healthcare Solutions, LLC, following a facility inspection which found the company's products, including Prelief and Urinozinc Prostate Health Formula to be adulterated because they were prepared, packed, or held under
Master antioxidant
Its unique properties and stability make it a compelling subject of study and a potential therapeutic agent in the field of pharmacology
Store lyophilized material at 4 F (20 C) or below in a sealed vial Allow the vial to reach room temperature before opening to prevent condensation Protect the peptide from prolonged exposure to light, heat, and humidity Use sterile laboratory equipment and appropriate aseptic technique during preparation Avoid repeated freezethaw cycles which may affect peptide stability Label all reconstituted samples with preparation date, solvent type, and concentration Following consistent handling procedures helps support reproducible results in biochemical assays and experimental model systems
Can it have a PE effect beyond healing if used